Clinical trial · Observational
BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer
NCT02458664CI-TRIAL-00020005BASE HSP110unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
We collect prospectively and retrospectively, patients' demographic, pathological, surgical, therapeutic and prognosis informations in a database. After patient's consent to collect tumoural samples of their colorectal cancer after resection. We will then be able to evaluate the impact of HSP110, a chaperon protein, on their prognosis. Other proteins (to be determined) will also be study, after.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Colon | Malignant Colon Neoplasm | ALIAS | 0.90 |
| Rectum Cancer | Rectal Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Genetic analysis on tumor kept in tumor bank | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Colo-rectal cancer
- description
- All patients undergoing curative colorectal cancer in general and digestive surgery department at Saint-Antoine hospital
- interventionNames
- Genetic: Genetic analysis on tumor kept in tumor bank
Primary outcomes (1)
- measure
- Recurrence free survival and Recurrence free survival after resection of the colon cancer
- timeFrame
- End of follow up : at least 3 years
- description
- 3 years for prospective patients, more for retrospective patients
Secondary outcomes (1)
- measure
- Overall survival
- timeFrame
- End of follow up : at least 3 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All patients undergoing curative colorectal cancer in general and digestive surgery department at Saint-Antoine hospital. * Patients reporting their non-opposition to the use of tissue samples taken from their specimen for research purposes. Exclusion Criteria: * Patients who did not report their non-opposition to the use of tissue samples taken from their specimen for research purposes.
References
Publications (0)
Data not yet available
No reference posted for this study.